Get the Stockscreener App
49.67
0.73%
0.36
After Hours:
49.67
Spdr Pharmaceuticals Etf stock is traded at $49.67, with a volume of 59,679.
It is up +0.73% in the last 24 hours and up +3.61% over the past month.
See More
Previous Close:
$49.31
Open:
$49.22
24h Volume:
59,679
Relative Volume:
0.99
Market Cap:
$229.97M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.95%
1M Performance:
+3.61%
6M Performance:
+20.53%
1Y Performance:
+7.98%
1-Day Range:
$49.22
$49.89
1-Week Range:
$48.29
$49.89
52-Week Range:
$35.22
$49.89
Spdr Pharmaceuticals Etf Stock (XPH) Company Profile
Name
Spdr Pharmaceuticals Etf
Sector
Industry
Phone
-
Address
-
Compare XPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XPH
Spdr Pharmaceuticals Etf
|
49.67 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
335.42 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
682.06 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
685.23 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
254.99 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
629.07 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Pharmaceuticals Etf Stock (XPH) Latest News
P Pharmaceuticals ETF stock responds to job market shiftsWeekly Trade Analysis & Fast Moving Stock Trade Plans - newser.com
Aug Analyst Calls: P Pharmaceuticals ETF stock enhance shareholder valueMarket Movers & Daily Chart Pattern Signals - nchmf.gov.vn
P Pharmaceuticals ETF stock enhance shareholder value2025 Earnings Impact & Real-Time Volume Surge Alerts - newser.com
P Pharmaceuticals ETF stock prepared for digital transition2025 Market WrapUp & Scalable Portfolio Growth Ideas - newser.com
P Pharmaceuticals ETF stock overpriced at current multiples2025 Retail Activity & Daily Chart Pattern Signal Reports - Trung tâm Dự báo KTTV quốc gia
P Pharmaceuticals ETF stock return to pre crash levelsProduct Launch & Daily Risk Controlled Trade Plans - Trung tâm Dự báo KTTV quốc gia
SPDR Series TrustSPDR S&P Pharmaceuticals ETF (SSGE.HM) latest stock news and headlines - Yahoo
ETFs to Watch Post JNJ's Q3 Earnings Surprise & Bullish Outlook - TradingView
XPH: Small-Cap Pharma Turns Higher, At Long Last (NYSEARCA:XPH) - Seeking Alpha
Seeking Alpha's healthcare quant picks ahead of Q3 earnings: McKesson, Incyte top-rated stocks - MSN
Short bets on S&P 500 Healthcare sector rises marginally to 1.91% in September; MRNA remains most shorted stock - MSN
P Pharmaceuticals ETF stock beat international competitionJuly 2025 Big Picture & Weekly Top Gainers Alerts - newser.com
SPDR Pharmaceuticals ETF Index (^KZP) options chain - Yahoo
P Pharmaceuticals ETF stock protected from inflationJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio - sharewise.com
INCY and ABBV lead S&P 500 healthcare gainers in Q3; MOH and ALGN lag - MSN
How to Invest in SPDR S&P Biotech ETF (XBI) - The Motley Fool
Pharma stocks at 15-year valuation lows may offer value – BMO’s Evan Seigerman - Seeking Alpha
Headlines Boost Pharma Stocks. Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Speak to Rally Into Year End - MSN
Headlines Boost Pharma Stocks. What the Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Say - Barron's
6 Best Health Care Funds and ETFs for 2025 - US News Money
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - inkl
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - inkl
Biopharma Stocks Rally After Trump Threatens 100% Pharmaceuticals Tariff - inkl
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit - TradingView
SPDR S&P Biotech ETF (XBI) Top 25 Holdings - TIKR.com
SPDR S&P Pharmaceuticals ETF $XPH Stake Boosted by Goldman Sachs Group Inc. - Defense World
Short bets on S&P 500 Healthcare sector eases in August; MRNA stays most shorted stock - Seeking Alpha
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing - Benzinga
The Best Health Care ETFs to Buy - Kiplinger
XLV Vs. IHE: Will Pharmaceuticals Outperform Healthcare? (NYSEARCA:XLV) - Seeking Alpha
Simplex Trading LLC Buys Shares of 627 SPDR S&P Pharmaceuticals ETF $XPH - Defense World
Drug Tariffs Finally Land. Why Pharma Stocks Are Breathing Easy. - inkl
Spdr Pharmaceuticals Etf Stock (XPH) Financials Data
There is no financial data for Spdr Pharmaceuticals Etf (XPH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.09%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):